SUVN N9503012
Alternative Names: SUVN-N9503012Latest Information Update: 21 Sep 2023
At a glance
- Originator Suven Life Sciences
- Class Antidementias; Antidepressants; Behavioural disorder therapies
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Behavioural disorders; Dementia; Depressive disorders